Separation Systems for Commercial Biotechnology

Report Highlights

The global market for commercial biotechnology separation systems reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.

Report Scope

Current and projected protein and biomolecule separation revenue forecasts during the forecast period (i.e., 2010 to 2016) are discussed.  Protein separation systems are playing important roles in new biopharmaceutical development.  Protein separation systems do not require U.S. Food and Drug Administration (FDA) approval, but the products produced from these processes do, and they must be produced in accordance with FDA good manufacturing practices (GMP) guidelines.  Thus, these separation procedures and equipment must pass FDA audits of the manufacturing process.  New products requiring separation technologies that have been approved by the FDA in 2009 and 2010 are covered, and those products expected to be approved within the forecast period are discussed.  Due to the timing of the writing of this report, the figures for 2011 are estimated except where actual results have been reported

The report includes analysis of the leading competitors, as well as emerging companies in the current global biomolecule separation market.  Profiles of the manufacturers of the leading products are analyzed, and their specific product strategies are outlined.  This report notes companies that are poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment.  This competitive environment is examined, with a special focus on the ways in which developing products and technologies are influencing the current standard of patient care.  Detailed profiles of the current market leaders and emerging companies are discussed in detail.

Market figures are based on revenues at the manufacturers’ level.  The base year for analysis and projection is 2010.  Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions, and expanded indications for existing products. 

This report also includes overviews and forecasts of the separations market by product, by company, and by geographic region for the period from 2010 to 2016.  The global market is analyzed, and data are provided for each segment. 

Sales figures are reported in U.S. dollars and reflect currency fluctuations within the performance of revenue change.  Revenue figures do not account for variation in local currencies.

All market share data are presented on a global basis unless specifically noted. 

Analyst Credentials

Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007.  Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development.